期刊文献+

胸腔置管联合透明质酸钠防治结核性胸膜炎胸膜肥厚:成本效果分析 被引量:4

Intrathoracic cannula combining with sodium hyaluronate to prevent pleural thickening of tuberculous pleurisy:cost/effective analysis
暂未订购
导出
摘要 目的探索防治结核性胸膜炎胸膜肥厚成本低、效果好的治疗方法。方法64例中至大量游离结核性胸腔积液患者随机分为治疗组和对照组。治疗组胸腔置管完全引流积液后注入透明质酸钠,对照组常规胸穿抽液。统计治疗3个月后2组花费的成本,进行成本效果分析及敏感度分析。结果59例患者参与最后结果分析。治疗3个月后治疗组、对照组胸膜肥厚发生率是6.7%、31.0%(有效率分别是:93.3%、69.0%)(P<0.05);成本效果比(C/E)是35.19,47.53,敏感度分析显示C/E35.63,49.00。结论胸腔置管联合透明质酸钠防治结核性胸膜炎胸膜肥厚是成本低、效果好的方法。 Objective To explore the method of lower cost and better results, to prevent pleural thickening(PT) of tuberculous pleurisy. Methods Sixty-four patients with middle to large plerural effusions were randomly assigned to a treatment group and a control group. Patients in treatment group given with sodium hyaluronate via central venous catheter into the thoracic cavity after pleural effusion was drainaged completely, while patients in control group received routine thoraeentesis. We calculated the cost after 3 months in two groups respectively and analyzed the cost-effectiveness and sensitivity. Results Fifty-nine patients were available for final analysis. The inci dence rate of PT at 3rd month were 6.7% in treatment group and 31.0% in control group(the effective rate: 93.3% vs. 69.0%, respectively) with statistically significant difference(P〈0.05) ; The cost/effective rate were 35.2 in the treatment group and 47.5 in the control group. Sensitivity analysis showed 35.6 in the treatment group and 49.00 in the control group. Conclusions Intrathoracic cannula combining with administration of sodium hyaluronate is a method of lower cost and better results to prevent pleural thickening of tuberculous pleurisy.
出处 《中国防痨杂志》 CAS 2009年第8期487-490,共4页 Chinese Journal of Antituberculosis
关键词 结核 胸膜/并发症 结核 胸膜/经济学 胸膜疾病 引流术 透明质酸 成本及成本分析 Tuberculosis, pleural/complications Tuberculosis, pleural/economics Pleural diseases Drainage Hyaluronic acid Costs and cost analysis
  • 相关文献

参考文献4

二级参考文献13

  • 1孔晓东.药物经济学:概念、方法和应用[J].国外医学(药学分册),1994,21(1):13-18. 被引量:429
  • 2朱正中.高聚金葡素在肿瘤综合治疗中的作用[J].肿瘤防治研究,1995,22(6):335-338. 被引量:21
  • 3王鋆,张钧.药物经济学成本-效果分析[J].药学实践杂志,1995,13(4):193-197. 被引量:462
  • 4国家统计局.中华人民共和国2000年国民经济和社会发展的统计公报[M].-,2001,2..
  • 5Sahn SA. Management of malignant pleural effusions [J]. Monaldi Arch Chest Dis, 2001 , 56(5): 394 ~399.
  • 6Hada M. Gan To Kagaku Ryoho. Report of two cases with pleural effusion and ascites that responded dramatically to the combination of thalidomide, celecoxib, irinotecan, and CDDP infused in thoracic and abdominal cavities [J]. 2004, 31(4): 613 ~617.
  • 7Taubert J. Management of malignant pleural effusion [J]. Nurs Clin North Am, 2001, 36(4): 665 -683.
  • 8Putnam JB Jr, Walsh GL, Swisher SG, et al. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter [J]. Ann Thornc Surg, 2000 , 69(2): 369 ~375.
  • 9Antunes G, Neville E. Management of malignant pleural effusions [J]. Thorax,2000, 55(12): 981 -983.
  • 10Braat EA, Collen A, Jie AF, et al. The inactivation of singlechain urokinase - type plasminogen activator by thrombin on cultured human endothelial cells [J]. Biochim Biophys Acta,2000,1497(3): 351 ~358.

共引文献18

同被引文献26

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部